The Impact of Omega Three Fatty Acids on Vascular Function in HIV
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.
Also called NCT01041521
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 129 participants
- Registry
-
NCT01041521
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01041521. Randomized; quadruple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2020-02-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Impact of Omega Three Fatty Acids on Vascular Function in HIV
- Acronym
- HOST
- Condition
- High Triglyceride Level
- Condition
- HIV Infection
- Intervention (Drug)
- Lovaza
- Lead sponsor
- Tufts University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct01041521- Content hash
eb33bc3a2480d8750dd1037e9e16beab71d3a3a5d9636b4ed8e88a7c4f1b39a2